Sponsor Dossier
Amgen
Sponsor Dossier for Amgen. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AJEMNYE
- Brand: AMGEVITA
- Brand: ARANESP
- Brand: BLINCYTO
- Brand: CORORA
- Brand: DEPTARGIS
- Brand: EVENITY
- Brand: GANVADO
- Device (sponsor): Subcutaneous/intramuscular injection set, medicated
About
Amgen is an Australian Private Company with ABN 31051057428, registered in NSW and currently active.
Portfolio
Amgen has 24 brands on the ARTG, of which 20 are indexable and 18 carry a Product Information document. 16 brands are PBS-listed, 17 have a PBAC outcome on record, and 15 have an AusPAR on record. Notable brands include AJEMNYE, AMGEVITA, ARANESP, BLINCYTO, CORORA, DEPTARGIS, EVENITY, GANVADO, IMDELLTRA, KANJINTI, KYPROLIS, LUMAKRAS.
Therapeutic focus
— Oncology: 10 brands — Musculoskeletal: 5 brands — Immunology: 4 brands — Haematology: 2 brands — Endocrinology: 1 brand — Cardiology: 1 brand — Neurology: 1 brand
PBS footprint
16 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-09-01, across 17 brands with a PBAC outcome on record. The latest AusPAR is 2026-03-17, across 15 brands with an AusPAR on record.